Lanean...
A Novel Calculator for Esophageal Adenocarcinoma Accurately Predicts Overall Survival Benefit from Neoadjuvant Chemoradiation
INTRODUCTION: Our group recently published that patients with clinically node negative (cN−) esophageal adenocarcinoma do not derive an overall survival (OS) benefit from neoadjuvant chemoradiation (nCRT) compared to clinically node positive (cN+) patients. The aim of this study was to develop a cal...
Gorde:
| Argitaratua izan da: | J Am Coll Surg |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836490/ https://ncbi.nlm.nih.gov/pubmed/28147252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2017.01.043 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|